Human kansl1/CENP-36/hMSL1v1 ORF/cDNA clone-Mammalian (Non-Viral Vector) plasmid (NM_001193466.2)

Cat. No.: pGMPC000163
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human kansl1/CENP-36/hMSL1v1 Non-Viral expression plasmid (overexpression vector) for mouse kansl1 overexpression in unique cell transient transfection and stable cell line development.


Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMPC000163
Gene Name kansl1
Accession Number NM_001193466.2
Gene ID 284058
Species Human
Product Type Mammalian (Non-Viral Vector) plasmid (overexpression)
Insert Length 3318 bp
Gene Alias CENP-36,hMSL1v1,KDVS,KIAA1267,MSL1v1,NSL1
Fluorescent Reporter Null
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGCTGCGATGGCGCCCGCTCTCACTGACGCAGCAGCTGAAGCACACCATATCCGGTTCAAACTGGCTCCCCCATCCTCTACCTTGTCCCCTGGCAGTGCCGAAAATAACGGCAACGCCAACATCCTTATTGCTGCCAACGGAACCAAAAGAAAAGCCATTGCTGCAGAGGATCCCAGCCTAGATTTCCGAAATAATCCTACCAAGGAAGACTTGGGAAAGCTGCAACCACTGGTGGCATCTTATCTCTGCTCTGATGTAACATCTGTTCCCTCAAAGGAGTCTTTGAAGTTGCAAGGGGTCTTCAGCAAGCAGACAGTCCTTAAATCTCATCCTCTCTTATCTCAGTCCTATGAACTCCGAGCTGAGCTGTTGGGGAGACAGCCAGTTTTGGAGTTTTCCTTAGAAAATCTTAGAACCATGAATACGAGTGGTCAGACAGCTCTGCCACAAGCACCTGTAAATGGGTTGGCTAAGAAATTGACTAAAAGTTCAACACATTCTGATCATGACAATTCCACTTCCCTCAATGGGGGAAAACGGGCTCTCACTTCATCTGCTCTTCATGGGGGTGAAATGGGAGGATCTGAATCTGGGGACTTGAAGGGGGGTATGACCAATTGCACTCTTCCACATAGAAGCCTTGATGTAGAACACACAACTTTGTATAGCAATAATAGCACTGCAAACAAATCCTCTGTCAATTCCATGGAACAGCCGGCACTTCAAGGAAGCAGTAGATTATCACCTGGTACAGACTCCAGCTCTAACTTGGGGGGTGTCAAATTGGAGGGTAAAAAGTCTCCCCTGTCTTCCATTCTTTTCAGTGCTTTAGATTCTGACACAAGGATAACAGCTTTACTGCGGCGACAGGCTGACATTGAGAGCCGTGCCCGCAGATTACAAAAGCGCTTACAGGTTGTGCAAGCCAAGCAGGTTGAGAGGCATATACAACATCAGCTGGGTGGATTTTTGGAGAAGACTTTGAGCAAACTGCCAAACTTGGAATCCTTGAGACCACGGAGCCAGTTGATGCTGACTCGAAAGGCTGAAGCTGCCTTGAGAAAAGCTGCCAGTGAGACCACCACTTCAGAGGGACTTAGCAACTTTCTGAAAAGCAATTCAATTTCAGAAGAATTGGAGAGATTTACAGCTAGTGGCATAGCCAACTTGAGGTGCAGTGAACAGGCATTTGATTCAGATGTCACTGACAGTAGTTCAGGAGGGGAGTCTGATATTGAAGAGGAAGAACTGACCAGAGCTGATCCCGAGCAGCGTCATGTACCCCTGAGACGCAGGTCAGAATGGAAATGGGCTGCAGACCGGGCAGCTATTGTCAGCCGCTGGAACTGGCTTCAGGCTCATGTTTCTGACTTGGAATATCGAATTCGTCAGCAAACAGACATTTACAAACAGATACGTGCTAATAAGGGGTTGATAGTTCTTGGGGAGGTACCTCCCCCAGAGCATACAACAGACTTATTTCTTCCACTTAGTTCTGAGGTGAAGACAGATCATGGGACTGATAAATTGATTGAGTCTGTTTCTCAGCCATTGGAAAACCATGGTGCCCCTATTATTGGTCATATTTCAGAGTCACTGTCTACCAAATCATGTGGAGCACTCAGACCTGTCAATGGAGTTATTAACACTCTTCAGCCTGTCTTGGCAGACCACATTCCAGGTGACAGCTCTGATGCTGAGGAACAATTACATAAGAAGCAACGACTGAATCTCGTCTCTTCATCATCTGATGGCACCTGTGTGGCAGCCCGGACACGTCCTGTACTGAGCTGTAAGAAGCGGAGGCTTGTTCGACCCAACAGCATCGTTCCTCTTTCCAAGAAGGTTCACCGGAACAGCACAATCCGCCCTGGCTGTGATGTGAATCCCTCCTGCGCACTGTGTGGTTCAGGCAGCATCAACACCATGCCTCCCGAAATTCACTATGAAGCCCCTCTGTTGGAACGTCTTTCCCAGTTGGACTCTTGTGTTCATCCTGTTCTAGCATTTCCAGATGATGTTCCCACAAGCCTGCATTTCCAGAGCATGCTGAAATCTCAGTGGCAGAACAAGCCTTTTGACAAAATCAAACCTCCCAAAAAGTTATCGCTTAAGCACAGAGCACCCATGCCGGGCAGTCTGCCAGATTCAGCTCGTAAGGACAGGCACAAATTGGTCAGCTCCTTCCTAACAACAGCCAAGCTGTCCCATCACCAAACCCGGCCTGACAGGACCCACAGGCAGCACTTAGACGATGTGGGGGCCGTGCCCATGGTGGAGCGAGTGACAGCGCCAAAAGCAGAGCGCTTGCTCAACCCACCACCACCCGTGCATGACCCAAACCACAGCAAAATGAGATTGCGAGACCATTCATCTGAGAGAAGTGAAGTGTTGAAGCATCACACAGACATGAGCAGTTCGAGCTACTTGGCAGCCACCCACCATCCTCCACACAGTCCCTTGGTGCGACAGCTCTCCACCTCCTCAGATTCCCCTGCACCCGCCAGCTCTAGCTCACAGGTTACAGCCAGCACATCGCAGCAGCCAGTAAGGAGGAGAAGGGGAGAGAGCTCATTTGATATTAACAACATTGTCATCCCAATGTCTGTTGCTGCAACAACTCGCGTAGAGAAACTGCAATACAAGGAAATCCTTACGCCCAGCTGGCGGGAGGTTGATCTTCAGTCTCTGAAGGGGAGTCCTGATGAGGAGAATGAAGAGATTGAGGACCTATCCGACGCAGCCTTCGCCGCCCTGCATGCCAAATGTGAGGAGATGGAGAGGGCACGGTGGCTGTGGACCACGAGTGTGCCACCCCAGCGGCGGGGCAGCAGGTCCTACAGGTCATCAGACGGCCGGACAACCCCCCAGCTGGGCAGTGCCAACCCCTCCACCCCCCAGCCTGCCTCCCCTGATGTCAGCAGTAGCCACTCTTTGTCAGAATACTCCCATGGTCAGTCCCCTAGGAGCCCCATTAGCCCGGAACTGCACTCAGCACCCCTCACCCCTGTGGCTCGGGACACTCCGCGACACTTAGCCAGTGAGGATACCCGTTGTTCCACACCAGAGCTGGGGCTGGATGAACAGTCTGTCCAGCCCTGGGAGCGGCGGACCTTCCCCCTGGCGCACAGTCCCCAGGCGGAGTGTGAGGACCAGCTGGATGCACAGGAGCGAGCAGCCCGCTGCACTCGACGCACCTCAGGCAGCAAGACTGGCCGGGAGACAGAGGCAGCGCCCACCTCGCCTCCCATTGTCCCCCTCAAGAGTCGGCATCTGGTGGCAGCAGCCACAGCTCAGCGCCCGACTCACAGATGA
ORF Protein Sequence MAAMAPALTDAAAEAHHIRFKLAPPSSTLSPGSAENNGNANILIAANGTKRKAIAAEDPSLDFRNNPTKEDLGKLQPLVASYLCSDVTSVPSKESLKLQGVFSKQTVLKSHPLLSQSYELRAELLGRQPVLEFSLENLRTMNTSGQTALPQAPVNGLAKKLTKSSTHSDHDNSTSLNGGKRALTSSALHGGEMGGSESGDLKGGMTNCTLPHRSLDVEHTTLYSNNSTANKSSVNSMEQPALQGSSRLSPGTDSSSNLGGVKLEGKKSPLSSILFSALDSDTRITALLRRQADIESRARRLQKRLQVVQAKQVERHIQHQLGGFLEKTLSKLPNLESLRPRSQLMLTRKAEAALRKAASETTTSEGLSNFLKSNSISEELERFTASGIANLRCSEQAFDSDVTDSSSGGESDIEEEELTRADPEQRHVPLRRRSEWKWAADRAAIVSRWNWLQAHVSDLEYRIRQQTDIYKQIRANKGLIVLGEVPPPEHTTDLFLPLSSEVKTDHGTDKLIESVSQPLENHGAPIIGHISESLSTKSCGALRPVNGVINTLQPVLADHIPGDSSDAEEQLHKKQRLNLVSSSSDGTCVAARTRPVLSCKKRRLVRPNSIVPLSKKVHRNSTIRPGCDVNPSCALCGSGSINTMPPEIHYEAPLLERLSQLDSCVHPVLAFPDDVPTSLHFQSMLKSQWQNKPFDKIKPPKKLSLKHRAPMPGSLPDSARKDRHKLVSSFLTTAKLSHHQTRPDRTHRQHLDDVGAVPMVERVTAPKAERLLNPPPPVHDPNHSKMRLRDHSSERSEVLKHHTDMSSSSYLAATHHPPHSPLVRQLSTSSDSPAPASSSSQVTASTSQQPVRRRRGESSFDINNIVIPMSVAATTRVEKLQYKEILTPSWREVDLQSLKGSPDEENEEIEDLSDAAFAALHAKCEEMERARWLWTTSVPPQRRGSRSYRSSDGRTTPQLGSANPSTPQPASPDVSSSHSLSEYSHGQSPRSPISPELHSAPLTPVARDTPRHLASEDTRCSTPELGLDEQSVQPWERRTFPLAHSPQAECEDQLDAQERAARCTRRTSGSKTGRETEAAPTSPPIVPLKSRHLVAAATAQRPTHR

Reference




    Data / case study


    Click to get more Data / Case study about the product.







    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.